카르바믹산,[(1R,3R)-3-(히드록시메틸)시클로펜틸]-,1,1-디메틸에틸에스테르(9CI)

카르바믹산,[(1R,3R)-3-(히드록시메틸)시클로펜틸]-,1,1-디메틸에틸에스테르(9CI)
카르바믹산,[(1R,3R)-3-(히드록시메틸)시클로펜틸]-,1,1-디메틸에틸에스테르(9CI) 구조식 이미지
카스 번호:
884006-56-8
한글명:
카르바믹산,[(1R,3R)-3-(히드록시메틸)시클로펜틸]-,1,1-디메틸에틸에스테르(9CI)
동의어(한글):
카르바믹산,[(1R,3R)-3-(히드록시메틸)시클로펜틸]-,1,1-디메틸에틸에스테르(9CI)
상품명:
CarbaMic acid, [(1R,3R)-3-(hydroxyMethyl)cyclopentyl]-, 1,1-diMethylethyl ester (9CI)
동의어(영문):
tert-Butyl N-[(1R,3R)-3-(hydroxymethyl)cyclopentyl]carbamate;Carbamic acid, [(1R,3R)-3-(hydroxymethyl) cyclopentyl]-, 1,1-dimethylethyl ester;CarbaMic acid, [(1R,3R)-3-(hydroxyMethyl)cyclopentyl]-, 1,1-diMethylethyl ester (9CI)
CBNumber:
CB92735075
분자식:
C11H21NO3
포뮬러 무게:
215.29
MOL 파일:
884006-56-8.mol

카르바믹산,[(1R,3R)-3-(히드록시메틸)시클로펜틸]-,1,1-디메틸에틸에스테르(9CI) 속성

끓는 점
334.9±11.0 °C(Predicted)
밀도
1.06±0.1 g/cm3(Predicted)
산도 계수 (pKa)
12.46±0.40(Predicted)

안전

카르바믹산,[(1R,3R)-3-(히드록시메틸)시클로펜틸]-,1,1-디메틸에틸에스테르(9CI) C화학적 특성, 용도, 생산

카르바믹산,[(1R,3R)-3-(히드록시메틸)시클로펜틸]-,1,1-디메틸에틸에스테르(9CI) 준비 용품 및 원자재

원자재

준비 용품


카르바믹산,[(1R,3R)-3-(히드록시메틸)시클로펜틸]-,1,1-디메틸에틸에스테르(9CI) 공급 업체

글로벌( 13)공급 업체
공급자 전화 이메일 국가 제품 수 이점
ATK CHEMICAL COMPANY LIMITED
+undefined-21-51877795
ivan@atkchemical.com China 32760 60
Hangzhou MolCore BioPharmatech Co.,Ltd.
+86-057181025280; +8617767106207
sales@molcore.com China 49739 58
Suzhou ARTK Medchem Co., Ltd.
+8618168183658
sales1@artkmedchem.com China 39009 58
Goodee Pharma Co., Ltd. 0512-62956210
yongyan@goodeepharma.com China 132 60
Shanghai CR Corporation Limited 021-80270511; 4006653949
fred.wen@crcorporation.cn China 10047 58
Jiangsu yize medical technology co. LTD 18962082606
3394205705@qq.com China 9773 58
Taizhou Nanfeng Pharmaceutical Research Institute 18616377689
nanfengdrug@163.com China 20566 58
Shanghai Haohong Pharmaceutical Co., Ltd. 4008210725 4008210725
malulu@leyan.com China 54986 58
Shanghai Ruipu Medical Technology Co., Ltd 15895968936
1018762393@qq.com China 10000 58
PharmaBlock Sciences (Nanjing), Inc. 025-86918232 4000255188
sales_china@pharmablock.com China 9792 58

Copyright 2019 © ChemicalBook. All rights reserved